New MRI technology for assessing kidney dysfunction
Explore the Value of New Magnetic Resonance Technology in Non-invasive Quantitative Assessment of Renal Dysfunction and Renal Fibrosis
This study is testing a new MRI technology to see if it can safely and accurately check for kidney problems without the need for invasive procedures.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | Tongji Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT06366529 on ClinicalTrials.gov |
What this trial studies
This study explores the use of advanced magnetic resonance imaging (MRI) technology to non-invasively evaluate renal insufficiency and renal fibrosis. Traditional methods like renal biopsy are invasive and carry risks, while MRI offers a safer alternative with high-resolution imaging capabilities. The goal is to develop a comprehensive assessment method that can improve the diagnosis and monitoring of kidney diseases, particularly chronic kidney disease (CKD) and acute kidney injury (AKI). By utilizing multi-parameter analysis, this approach aims to provide a more accurate understanding of kidney pathology without the complications associated with invasive procedures.
Who should consider this trial
Good fit: Ideal candidates include individuals with clinically suspected or confirmed renal insufficiency who are scheduled for an MRI examination.
Not a fit: Patients with certain medical implants, claustrophobia, or those unable to tolerate the MRI procedure may not benefit from this study.
Why it matters
Potential benefit: If successful, this technology could lead to safer and more accurate assessments of kidney health, improving patient outcomes and treatment options.
How similar studies have performed: While the use of MRI in kidney assessment is gaining attention, this specific application of advanced MRI technology for renal fibrosis evaluation is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with clinically suspected or confirmed renal insufficiency and prescribed MR examination; 2. Age/gender: no limit; 3. Patients who voluntarily participate in clinical trials and sign written informed consent forms Exclusion Criteria: 1. Patients with pacemakers of unknown material, metal implants in the body, neurostimulators, and claustrophobia, etc. 2. Patients who cannot tolerate sufficient breath-holding for adequate MR examination
Where this trial is running
Wuhan, Hubei
- Tongji hospital, NO.1095 jiefang avenue — Wuhan, Hubei, China (Recruiting)
Study contacts
- Study coordinator: Zhen Li, Doctor
- Email: zhenli@hust.edu.cn
- Phone: 02783663543
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.